The "Fabry Disease Market - A Global and Regional Analysis: Focus on Route of Administration and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.The ...
Pharmaceutical Technology on MSN
Metagenomi culls 25% of its workforce and replaces CEO in reshuffle
Along with the layoffs, the reshuffle includes prioritisation of pipeline assets with the “highest probability of success.” ...
Treatment Market is projected to grow at a healthy rate of around 13% by 2026. This growth is primarily driven by the ...
Geneventiv said the FDA had "positive" feedback in a meeting on developing GENV-HEM, the company's gene therapy for ...
WEX Inc. (WEX) 7th Annual Healthcare Symposium November 14, 2025 9:50 AM ESTCompany ParticipantsChris ByrdConference Call ParticipantsDaniel ...
The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...
By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, actively working to remove obstacles to innovation.
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
After comments talking about the return of Jaylon Johnson late in the season by coaches, they're now opening his 21-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback